Filing Details
- Accession Number:
- 0001596783-21-000150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-21 19:16:37
- Reporting Period:
- 2021-10-20
- Accepted Time:
- 2021-10-21 19:16:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861137 | P Thomas Castellano | Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Svp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-10-20 | 2,307 | $134.00 | 15,398 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
- Includes restricted stock units.
Billionaire Hedge Funds
